The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Verrica Pharmaceuticals Inc(NASDAQ:VRCA) 
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; which has completed phase II clinical trial fo...
Website: http://www.verrica.com
Founded: 2013
Full Time Employees: 17
Sector: Healthcare
Industry: Biotechnology
Verrica Pharmaceuticals Days Payable Outstanding ttm (DPO)
Verrica Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Verrica Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Verrica Pharmaceuticals Op Cashflow Per Share ttm
Verrica Pharmaceuticals Free Cashflow Per Share ttm
Verrica Pharmaceuticals Cash Per Share ttm
Verrica Pharmaceuticals P/S ratio ttm
Verrica Pharmaceuticals (GAAP) P/E ratio ttm
Verrica Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.